Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease: Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial

Atsushi Tanaka; Michio Shimabukuro; Noritaka MacHii; Hiroki Teragawa; Yosuke Okada; Kosuke R. Shima; Toshinari Takamura; Isao Taguchi; Itaru Hisauchi; Shigeru Toyoda; Yasushi Matsuzawa; Hirofumi Tomiyama; Minako Yamaoka-Tojo; Hisako Yoshida; Yasunori Sato; Yumi Ikehara; Shinichiro Ueda; Yukihito Higashi; Koichi Node

doi:10.2337/dc19-1177

Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease: Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial

Atsushi Tanaka, Michio Shimabukuro, Noritaka MacHii, Hiroki Teragawa, Yosuke Okada, Kosuke R. Shima, Toshinari Takamura, Isao Taguchi, Itaru Hisauchi, Shigeru Toyoda, Yasushi Matsuzawa, Hirofumi Tomiyama, Minako Yamaoka-Tojo, Hisako Yoshida, Yasunori Sato, Yumi Ikehara, Shinichiro Ueda, Yukihito Higashi, Koichi Node

Department of Preventive Medicine and Public Health

Research output: Contribution to journal › Letter

1 Citation (Scopus)

Original language	English
Pages (from-to)	E159-E161
Journal	Diabetes care
Volume	42
Issue number	10
DOIs	https://doi.org/10.2337/dc19-1177
Publication status	Published - 2019 Oct 1

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialised Nursing

Cite this

Tanaka, A., Shimabukuro, M., MacHii, N., Teragawa, H., Okada, Y., Shima, K. R., Takamura, T., Taguchi, I., Hisauchi, I., Toyoda, S., Matsuzawa, Y., Tomiyama, H., Yamaoka-Tojo, M., Yoshida, H., Sato, Y., Ikehara, Y., Ueda, S., Higashi, Y., & Node, K. (2019). Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease: Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial. Diabetes care, 42(10), E159-E161. https://doi.org/10.2337/dc19-1177

Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease : Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial. / Tanaka, Atsushi; Shimabukuro, Michio; MacHii, Noritaka; Teragawa, Hiroki; Okada, Yosuke; Shima, Kosuke R.; Takamura, Toshinari; Taguchi, Isao; Hisauchi, Itaru; Toyoda, Shigeru; Matsuzawa, Yasushi; Tomiyama, Hirofumi; Yamaoka-Tojo, Minako; Yoshida, Hisako; Sato, Yasunori; Ikehara, Yumi; Ueda, Shinichiro; Higashi, Yukihito; Node, Koichi.

In: Diabetes care, Vol. 42, No. 10, 01.10.2019, p. E159-E161.

Research output: Contribution to journal › Letter

Tanaka, A, Shimabukuro, M, MacHii, N, Teragawa, H, Okada, Y, Shima, KR, Takamura, T, Taguchi, I, Hisauchi, I, Toyoda, S, Matsuzawa, Y, Tomiyama, H, Yamaoka-Tojo, M, Yoshida, H, Sato, Y, Ikehara, Y, Ueda, S, Higashi, Y & Node, K 2019, 'Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease: Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial', Diabetes care, vol. 42, no. 10, pp. E159-E161. https://doi.org/10.2337/dc19-1177

Tanaka, Atsushi ; Shimabukuro, Michio ; MacHii, Noritaka ; Teragawa, Hiroki ; Okada, Yosuke ; Shima, Kosuke R. ; Takamura, Toshinari ; Taguchi, Isao ; Hisauchi, Itaru ; Toyoda, Shigeru ; Matsuzawa, Yasushi ; Tomiyama, Hirofumi ; Yamaoka-Tojo, Minako ; Yoshida, Hisako ; Sato, Yasunori ; Ikehara, Yumi ; Ueda, Shinichiro ; Higashi, Yukihito ; Node, Koichi. / Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease : Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial. In: Diabetes care. 2019 ; Vol. 42, No. 10. pp. E159-E161.

@article{0b8ce39304124596bdff117caa309dc0,

title = "Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease: Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial",

author = "Atsushi Tanaka and Michio Shimabukuro and Noritaka MacHii and Hiroki Teragawa and Yosuke Okada and Shima, {Kosuke R.} and Toshinari Takamura and Isao Taguchi and Itaru Hisauchi and Shigeru Toyoda and Yasushi Matsuzawa and Hirofumi Tomiyama and Minako Yamaoka-Tojo and Hisako Yoshida and Yasunori Sato and Yumi Ikehara and Shinichiro Ueda and Yukihito Higashi and Koichi Node",

year = "2019",

month = oct,

day = "1",

doi = "10.2337/dc19-1177",

language = "English",

volume = "42",

pages = "E159--E161",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "10",

}

TY - JOUR

T1 - Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular disease

T2 - Results from the multicenter, randomized, placebo- controlled, double-blind EMBLEM trial

AU - Tanaka, Atsushi

AU - Shimabukuro, Michio

AU - MacHii, Noritaka

AU - Teragawa, Hiroki

AU - Okada, Yosuke

AU - Shima, Kosuke R.

AU - Takamura, Toshinari

AU - Taguchi, Isao

AU - Hisauchi, Itaru

AU - Toyoda, Shigeru

AU - Matsuzawa, Yasushi

AU - Tomiyama, Hirofumi

AU - Yamaoka-Tojo, Minako

AU - Yoshida, Hisako

AU - Sato, Yasunori

AU - Ikehara, Yumi

AU - Ueda, Shinichiro

AU - Higashi, Yukihito

AU - Node, Koichi

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85072546608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072546608&partnerID=8YFLogxK

U2 - 10.2337/dc19-1177

DO - 10.2337/dc19-1177

M3 - Letter

C2 - 31533913

AN - SCOPUS:85072546608

VL - 42

SP - E159-E161

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 10

ER -

Access to Document

10.2337/dc19-1177